GoodRx Holdings (GDRX) Change in Account Payables (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Change in Account Payables data on file, last reported at -$4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables fell 1829.02% year-over-year to -$4.9 million; the trailing twelve-month figure through Mar 2026 stood at -$1.1 million (up 91.38% YoY), and the FY2025 full-year result was $4.1 million, up 125.94% from the prior year.
• Change in Account Payables improved to -$4.9 million in Q1 2026, from -$10.5 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $25.5 million in Q3 2023 to a low of -$15.6 million in Q2 2024.
• A 5-year average of -$323588.2 and a median of -$2.5 million in 2023 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables surged 10030.77% in 2022 and tumbled 1829.02% in 2026, its largest moves.
• Tracing GDRX's Change in Account Payables over 5 years: stood at $7.1 million in 2022, then slumped by 134.76% to -$2.5 million in 2023, then surged by 396.17% to $7.3 million in 2024, then plunged by 243.2% to -$10.5 million in 2025, then jumped by 53.0% to -$4.9 million in 2026.
• Business Quant data shows GDRX's Change in Account Payables at -$4.9 million in Q1 2026, -$10.5 million in Q4 2025, and $3.5 million in Q3 2025.